
The research laboratories of the Children's Cancer Centre are within the Murdoch Childrens Research Institute, Royal Children's Hospital and affiliated with the University of Melbourne Department of Paediatrics.
Proudly supported by
Australian Cancer Research Foundation has committed $1 million to fund our innovative research to make discoveries in the fight against childhood cancer.
Cell Biology Laboratory
|
Apoptosis is one mechanism by which a cell can kill itself. It is a normal, physiological process that can occur in response to numerous physiological and pathological stimuli. Survival of many cell types requires continuous signals from cytokines, and when these signals are lost, these cells undergo apoptosis. Completing the signalling pathway from cytokine receptor to apoptotic effectors is one of the holy grails of apoptosis research. A molecular understanding of the point at which a cell is irrevocably committed to die would have far reaching implications for our understanding of the role of apoptosis in human disease, because it is only those molecules that determine whether a cell commits to die that have potential to be oncogenes or tumour suppressors, and hence, therapeutic targets. Growth and survival of haemopoietic cells is regulated by growth factors such as Interleukin-3 (IL-3). When IL-3 is removed, dependent cells kill themselves by a mechanism that can be regulated by the Bcl-2 family of apoptosis regulators, hence the term "Bcl-2-inhibitable" pathway (or "intrinsic pathway") (See Figure 1). We have generated a unique and powerful resource, a comprehensive panel of IL-3 dependent cell lines derived from gene-deleted mice lacking components of the apoptosis mechanism. We want to determine which genes, when deleted, permit clonogenic survival in response to IL-3 withdrawal. Recently we found that cells lacking Puma, a Bcl-2 family member, can survive periods of IL-3 deprivation, and then form colonies when IL-3 is restored. We sre studying the mechanisms by which Puma regulates the response to IL-3 withdrawal, and how Puma itself is regulated, whilst continung to identify other genes that have a similar effects. We are also interested in the kinase signaling molecules thought to play a role in IL-3 survival signaling. We have generated IL-3 dependent cell lines lacking AKT1 to determine the effects of AKT1 depletion on IL-3 signaling and a lentiviral system that permits us to induce AKT1 or AKT2 expression to investigate the effects of over-expression of these kinases. |
|
A/Professor Paul EkertCell Biology Laboratory Group Leader Children's Cancer Centre Murdoch Childrens Research Institute Royal Children's Hospital Flemington Road Parkville Victoria 3052 Australia T +61 3 9345 5823 F +61 3 9345 4996 E |
Cell Biology Laboratory research projects, publications, achievements & collaborators
Proudly Supported By
Australian Cancer Research Foundation has committed $1 million to fund our innovative research to make discoveries in the fight against childhood cancer.


A/Professor Paul Ekert